11 September 2024
Forbion Leads $14m Series A in SOLASTA Bio to advance development and commercialisation of first-in-class sustainable crop protection solutions
Forbion Leads $14m Series A in SOLASTA Bio
Joy Faucher, Partner at Forbion for its BioEconomy Fund noted, “As traditional insect control agents struggle with resistance and impact to biodiversity, SOLASTA’s demonstrated cost-effective, sustainable and high-efficacy solution is poised to transform the crop protection market. We are excited to support SOLASTA in continuing the development and commercialisation of its first-in-class peptide products.”
“We have come a long way since setting out on this journey 3 years ago. We have developed our unique technology platform to address grower pain points, have expanded operations to the US and have brough together outstanding competencies in technology and agribusiness. The results of our field trials have been hugely encouraging, demonstrating high efficacy of biopeptides against target insect pests, as effective or better than standard insecticides” said Shireen Davies PhD, FRSE, CEO and co-founder, SOLASTA Bio. “With the Series A, it’s time for SOLASTA Bio to kick on to the next level and successfully hit our targets for commercialisation.”
More articles
02 December 2024
SOLASTA Bio completes $14m Series A to accelerate nature-inspired crop protection
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round to accelerate the development of its ...
02 December 2024
SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics
UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million